186 related articles for article (PubMed ID: 3592654)
21. The effect of clofibrate on the phospholipid composition of the peroxisomal membranes in mouse liver.
Crane DI; Masters CJ
Biochim Biophys Acta; 1986 Apr; 876(2):256-63. PubMed ID: 3955065
[TBL] [Abstract][Full Text] [Related]
22. CoA esters of valproic acid and related metabolites are oxidized in peroxisomes through a pathway distinct from peroxisomal fatty and bile acyl-CoA beta-oxidation.
Vamecq J; Vallee L; Fontaine M; Lambert D; Poupaert J; Nuyts JP
FEBS Lett; 1993 May; 322(2):95-100. PubMed ID: 8482393
[TBL] [Abstract][Full Text] [Related]
23. The effect of beclobric acid and clofibric acid on peroxisomal beta-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes.
Blaauboer BJ; van Holsteijn CW; Bleumink R; Mennes WC; van Pelt FN; Yap SH; van Pelt JF; van Iersel AA; Timmerman A; Schmid BP
Biochem Pharmacol; 1990 Aug; 40(3):521-8. PubMed ID: 2383284
[TBL] [Abstract][Full Text] [Related]
24. Fatty acid metabolism in liver of rats treated with hypolipidemic sulphur-substituted fatty acid analogues.
Asiedu D; Aarsland A; Skorve J; Svardal AM; Berge RK
Biochim Biophys Acta; 1990 May; 1044(2):211-21. PubMed ID: 1971517
[TBL] [Abstract][Full Text] [Related]
25. 31P-NMR of liver peroxisome membranes from normal and clofibrate-treated rats.
Serafini B; Cimini A; Sette M; Sartori C
Cell Mol Biol (Noisy-le-grand); 1993 Jul; 39(5):479-89. PubMed ID: 8397028
[TBL] [Abstract][Full Text] [Related]
26. Role of peroxisomal fatty acyl-CoA beta-oxidation in phospholipid biosynthesis.
Hayashi H; Takahata S
Arch Biochem Biophys; 1991 Feb; 284(2):326-31. PubMed ID: 1989516
[TBL] [Abstract][Full Text] [Related]
27. Influence of chronic administration of valproate on ultrastructure and enzyme content of peroxisomes in rat liver and kidney. Oxidation of valproate by liver peroxisomes.
Ponchaut S; Draye JP; Veitch K; Van Hoof F
Biochem Pharmacol; 1991 May; 41(10):1419-28. PubMed ID: 2018550
[TBL] [Abstract][Full Text] [Related]
28. Purification of peroxisomes from livers of normal and clofibrate-treated mice.
Crane DI; Hemsley AC; Masters CJ
Anal Biochem; 1985 Aug; 148(2):436-45. PubMed ID: 3933379
[TBL] [Abstract][Full Text] [Related]
29. Identification of beta-oxidation enzymes among peroxisomal polypeptides. Increase in Coomassie blue-stainable protein after clofibrate treatment.
Lazarow PB; Fujiki Y; Mortensen R; Hashimoto T
FEBS Lett; 1982 Dec; 150(2):307-10. PubMed ID: 7160475
[No Abstract] [Full Text] [Related]
30. Involvement of calmodulin- and protein kinase C-related mechanism in an induction process of peroxisomal fatty acid oxidation-related enzymes by hypolipidemic peroxisome proliferators.
Watanabe T; Okawa S; Itoga H; Imanaka T; Suga T
Biochim Biophys Acta; 1992 Apr; 1135(1):84-90. PubMed ID: 1591274
[TBL] [Abstract][Full Text] [Related]
31. Clofibrate does not induce peroxisomal 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestanoyl coenzyme A oxidation in rat liver. Evidence that this reaction is catalyzed by an enzyme system different from that of peroxisomal acyl-coenzyme A oxidation.
Pedersen JI; Hvattum E; Flatabø T; Björkhem I
Biochem Int; 1988 Jul; 17(1):163-9. PubMed ID: 3190714
[TBL] [Abstract][Full Text] [Related]
32. Factors which can influence beta-oxidation by peroxisomes isolated from livers of clofibrate treated rats. Some properties of peroxisomal fractions isolated in a self-generated Percoll gradient by vertical rotor centrifugation.
Osmundsen H
Int J Biochem; 1982; 14(10):905-14. PubMed ID: 7128908
[TBL] [Abstract][Full Text] [Related]
33. Aging-related decrease in liver peroxisomal fatty acid oxidation in control and clofibrate-treated mice. A biochemical study and mechanistic approach.
Périchon R; Bourre JM
Mech Ageing Dev; 1996 Jun; 87(2):115-26. PubMed ID: 8783194
[TBL] [Abstract][Full Text] [Related]
34. Very long chain fatty acid beta-oxidation by rat liver mitochondria and peroxisomes.
Singh H; Derwas N; Poulos A
Arch Biochem Biophys; 1987 Dec; 259(2):382-90. PubMed ID: 3426234
[TBL] [Abstract][Full Text] [Related]
35. Alkylthio acetic acids (3-thia fatty acids)--a new group of non-beta-oxidizable peroxisome-inducing fatty acid analogues--II. Dose-response studies on hepatic peroxisomal- and mitochondrial changes and long-chain fatty acid metabolizing enzymes in rats.
Berge RK; Aarsland A; Kryvi H; Bremer J; Aarsaether N
Biochem Pharmacol; 1989 Nov; 38(22):3969-79. PubMed ID: 2574577
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of a major integral membrane polypeptide of rat liver peroxisomes on free polysomes.
Fujiki Y; Rachubinski RA; Lazarow PB
Proc Natl Acad Sci U S A; 1984 Nov; 81(22):7127-31. PubMed ID: 6594687
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome proliferation and oxidative stress mediated by activated oxygen species in plant peroxisomes.
Palma JM; Garrido M; Rodríguez-García MI; del Río LA
Arch Biochem Biophys; 1991 May; 287(1):68-74. PubMed ID: 1897996
[TBL] [Abstract][Full Text] [Related]
38. A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug.
Lazarow PB; De Duve C
Proc Natl Acad Sci U S A; 1976 Jun; 73(6):2043-6. PubMed ID: 180535
[TBL] [Abstract][Full Text] [Related]
39. A characteristic membrane protein of liver peroxisomes inducible by clofibrate.
Hüttinger M; Goldenberg H; Kramar R
Biochim Biophys Acta; 1979 Dec; 558(2):251-4. PubMed ID: 508747
[TBL] [Abstract][Full Text] [Related]
40. Hypolipidemic effect and enhancement of peroxisomal beta-oxidation in the liver of rats by sodium-(E)-3-(4-(3-pyridylmethyl)phenyl)-2-methyl propenoate (OKY-1581), a potent inhibitor of TxA2 synthetase.
Watanabe T; Utsugi M; Mitsukawa M; Suga T; Fujitani H
J Pharmacobiodyn; 1986 Dec; 9(12):1023-31. PubMed ID: 3572715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
